JP2020508074A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020508074A5 JP2020508074A5 JP2019546398A JP2019546398A JP2020508074A5 JP 2020508074 A5 JP2020508074 A5 JP 2020508074A5 JP 2019546398 A JP2019546398 A JP 2019546398A JP 2019546398 A JP2019546398 A JP 2019546398A JP 2020508074 A5 JP2020508074 A5 JP 2020508074A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cdr
- set forth
- position corresponding
- chain variable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical group COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 claims 25
- 102000009410 Chemokine receptor Human genes 0.000 claims 4
- 108050000299 Chemokine receptor Proteins 0.000 claims 4
- 206010028980 Neoplasm Diseases 0.000 claims 3
- 201000011510 cancer Diseases 0.000 claims 3
- 208000027866 inflammatory disease Diseases 0.000 claims 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022205168A JP2023052023A (ja) | 2017-02-27 | 2022-12-22 | Ｃｘｃｒ２抗体及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2017900656A AU2017900656A0 (en) | 2017-02-27 | CXCR2 antibodies | |
| AU2017900656 | 2017-02-27 | ||
| PCT/IB2018/000253 WO2018154391A1 (en) | 2017-02-27 | 2018-02-27 | Cxcr2 antibodies and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022205168A Division JP2023052023A (ja) | 2017-02-27 | 2022-12-22 | Ｃｘｃｒ２抗体及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020508074A JP2020508074A (ja) | 2020-03-19 |
| JP2020508074A5 true JP2020508074A5 (enExample) | 2021-04-08 |
| JP7562258B2 JP7562258B2 (ja) | 2024-10-07 |
Family
ID=63253562
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019546398A Active JP7562258B2 (ja) | 2017-02-27 | 2018-02-27 | Ｃｘｃｒ２抗体及びその使用 |
| JP2022205168A Pending JP2023052023A (ja) | 2017-02-27 | 2022-12-22 | Ｃｘｃｒ２抗体及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022205168A Pending JP2023052023A (ja) | 2017-02-27 | 2022-12-22 | Ｃｘｃｒ２抗体及びその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11053319B2 (enExample) |
| EP (1) | EP3585816A4 (enExample) |
| JP (2) | JP7562258B2 (enExample) |
| KR (1) | KR102673489B1 (enExample) |
| CN (1) | CN110637034B (enExample) |
| AU (1) | AU2018224391B2 (enExample) |
| CA (1) | CA3054616A1 (enExample) |
| WO (1) | WO2018154391A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018154391A1 (en) | 2017-02-27 | 2018-08-30 | Monash University | Cxcr2 antibodies and uses thereof |
| CA3108071A1 (en) | 2018-08-01 | 2020-02-06 | Cephalon, Inc. | Anti-cxcr2 antibodies and uses thereof |
| US20220332835A1 (en) * | 2019-09-04 | 2022-10-20 | Shanghaitech University | Anti-cxcr2 antibodies and uses thereof |
| TWI825687B (zh) * | 2021-04-26 | 2023-12-11 | 高雄醫學大學 | 抗ｃｘｃｒ２抗體及其用途 |
| KR20250001497A (ko) * | 2023-06-28 | 2025-01-07 | (재) 스크립스코리아항체연구원 | 항-cxcr2 항체 및 이의 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5440021A (en) * | 1991-03-29 | 1995-08-08 | Chuntharapai; Anan | Antibodies to human IL-8 type B receptor |
| KR101650995B1 (ko) | 2010-11-08 | 2016-08-25 | 노파르티스 아게 | Ｃｘｃｒ２ 결합 폴리펩티드 |
| US9328174B2 (en) | 2012-05-09 | 2016-05-03 | Novartis Ag | Chemokine receptor binding polypeptides |
| EP2986642A1 (en) | 2013-04-17 | 2016-02-24 | MorphoSys AG | Antibodies targeting specifically human cxcr2 |
| WO2015169811A2 (en) * | 2014-05-06 | 2015-11-12 | Medimmune Limited | Anti-cxc chemokine receptor-2 binding molecules and uses thereof |
| WO2018129261A1 (en) * | 2017-01-05 | 2018-07-12 | Brown University | Methods and compositions relating to anti-chi3l1 antibody reagents |
| WO2018154391A1 (en) | 2017-02-27 | 2018-08-30 | Monash University | Cxcr2 antibodies and uses thereof |
-
2018
- 2018-02-27 WO PCT/IB2018/000253 patent/WO2018154391A1/en not_active Ceased
- 2018-02-27 CN CN201880027752.3A patent/CN110637034B/zh active Active
- 2018-02-27 JP JP2019546398A patent/JP7562258B2/ja active Active
- 2018-02-27 EP EP18758109.5A patent/EP3585816A4/en active Pending
- 2018-02-27 KR KR1020197027809A patent/KR102673489B1/ko active Active
- 2018-02-27 AU AU2018224391A patent/AU2018224391B2/en active Active
- 2018-02-27 US US15/907,208 patent/US11053319B2/en active Active
- 2018-02-27 CA CA3054616A patent/CA3054616A1/en active Pending
-
2022
- 2022-12-22 JP JP2022205168A patent/JP2023052023A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020508074A5 (enExample) | ||
| JP2018507220A5 (enExample) | ||
| JP2023123726A5 (enExample) | ||
| JP2017113019A5 (enExample) | ||
| JP2017500018A5 (enExample) | ||
| CN115702008A (zh) | 抗体药物偶联物 | |
| JP2017079785A5 (enExample) | ||
| FI3625259T3 (fi) | Anti-sirp-alfa vasta-aineet | |
| JP2014533279A5 (enExample) | ||
| JP2019505527A5 (enExample) | ||
| JP2017113028A5 (enExample) | ||
| JP2015534578A5 (enExample) | ||
| JP2017529838A5 (enExample) | ||
| JP2015531750A5 (enExample) | ||
| JP2016519650A5 (enExample) | ||
| JP2016536361A5 (enExample) | ||
| JP2016500673A5 (enExample) | ||
| JP2015527318A5 (enExample) | ||
| JP2009539349A5 (enExample) | ||
| JP2009521909A5 (enExample) | ||
| JP2025032102A5 (enExample) | ||
| JP2017510567A5 (enExample) | ||
| JP2016094424A5 (enExample) | ||
| RU2017132432A (ru) | Конъюгаты антитело-лекарственное средство (adc), которые связываются с белками flt3 | |
| JP2010520290A5 (enExample) |